Enable Innovative Drug Discover with DEL, FBDD and SBDD
OpenDEL® has previously been released by HitGen as a self-serve product in 2015 (https://www.nature.com/articles/d43747-020-00040-4). After several years of evolution, it now contains small molecule DELs with high diversity and drug-like space and helps to increase the possibility of finding potential hits in an efficient and cost-effective manner.
YouTube:https://www.youtube.com/watch?v=7YvpolqnSU0
What are included in OpenDEL®?
OpenDEL® contains DEL libraries for affinity selection and other materials necessary for DEL selections, including PCR forward primer (Primer F), PCR reverse primer (Primer R), qPCR standard curve sample, Salmon sperm DNA (ssDNA) and empty tubes. Standard selection protocol is provided in the manual.
How does OpenDEL® work?
Target selection
Researchers will determine the details of the affinity selection protocol, using their deep knowledge of their targets. HitGen provides the basic screening protocol, DEL information (reagents and codon information) and free consultation services.
Hit generation
The post-selection samples can be decoded by HitGen or user. If the sequencing data is generated at HitGen, raw mapping data with feature intensity will be provided to user.
Hit validation
The proposed potential hits through data analysis could be re-synthesized on-DNA for further confirmation of the binding ligands or off-DNA for activity validation via appropriate biochemical, biophysical or cellular assays.
The advantages of OpenDEL®
Transparent: All DEL information (reagents and codons) is open to clients
Knowledge-sharing: Technical supports on self-service selection, sequencing and analysis
Reliable: Decent compound diversity with robust chemistry and strict library QC
Affordable: An affordable product that is easily accessible
HitGen Inc.
Building C2, NO.8, Huigu 1st East Road
Tianfu International Bio-Town,
Shuangliu District, Chengdu City,
Sichuan Province,P.R. China
Tel : +86-28-8519-7385
HitGen Pharmaceuticals Inc.(US Subsidiary)
Tel : +1-(508)-840-9646
Vernalis (R&D) Limited (UK Subsidiary)
Granta Park,Great Abington
Cambridge,CB21 6GB
United Kingdom
Tel : +44(0)1223-895555
We use cookies to provide a better web experience.
By using our site, you acknowledge our use of cookies and please read our Cookie Notice for
More information